[HSF] (OT) Drug Eluting Stents of the market?

[Ramaiah, Chandrashekar]

Dear Hal,
This could turn in to a major problem for not only the companies but also for the Hospitals and Cardiologists. Most of these stents were used off label.
I hope the hospitals realize and stop the cardiologists from using it indiscriminately before the Lawers jump in.
Chand

-----Original Message-----
From: "Hgrmd at aol.com" <Hgrmd at aol.com>
To: "OpenHeart-L at lists.hsforum.com" <OpenHeart-L at lists.hsforum.com>
Sent: 11/23/06 8:48 AM
Subject: Re: [HSF] (OT) Drug Eluting Stents of the market?

Dear Chand,
  Thanks for referring me to the MSNIBC link.  That report is  exactly what I 
have been telling my referrals for the last few months.  I  have no doubts 
that the legal fallout is going to be tremendous.  If  fallacious data on 
silicone breast implants could bankrupt Dow Chemical 15 years  ago, think what a 
real threat, DES, could do to Boston Scientific and J &  J.  As to what this 
means to cardiac surgery, I hope and believe that the  cards will be less likely 
to stent stable 3VD for the time being.  This  should translate into a 
stabilization or increase in CABG.  Time will  tell.
Hal
_______________________________________________
OpenHeart-L mailing list

Send postings to:
 OpenHeart-L at lists.hsforum.com

To UNSUBSCRIBE, to CHANGE email address, or to view archives:
http://mmp.cjp.com/mailman/listinfo/openheart-l

All messages transmitted by the OpenHeart-L are subject to the policies and 
disclaimers posted at:
http://www.hsforum.com/listdisclaim
-----------------------------------------